Abstract

Sparfloxacin (SPFX) and levofloxacin (LVFX) with ultraviolet-A (UVA) irradiation have been reported to induce skin inflammation due to phototoxicity in Balb/c mice. We examined the production of arachidonic acid metabolites induced by quinolone phototoxicity in Balb/c 3T3 mouse fibroblast cells in vitro. The cells were simultaneously treated with SPFX or LVFX at 1,10, or 100 μM and UVA irradiation for 5 min (0.5 J/cm2). They were then cultured in quinolone-free medium for 24 hr, and the concentrations of prostaglandin E2 (PGE2 6-ketoprostaglandin F1α (6-keto-PGF1α), and leukotriene B4 (LTB4) in the incubation medium were measured. Furthermore, the effect of quinolone photoproducts on the production of the inflammatory mediators and that of indomethacin on PGE2 level were also examined. Treatment with SPFX at 100 μM plus UVA irradiation markedly increased levels of PGE2 and 6-keto-PGF1α but not that of LTB SPFX or LVFX alone at up to 100 μM, 100 μM SPFX, or 100μM LVFX, or less plus UVA irradiation, or UVA-preirradiated quinolone up to 100μM had no effect. indomethacin even at 0.1 μM completely inhibited the PGE2 elevation induced by 100 μM SPFX with UVA. These results suggest that PGs released from dermal fibroblasts in the simultaneous presence of quinolone and UVA could contribute in part to the development of skin inflammation in vivo.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call